Held from September 5 9, 2026, the 41st Annual Congress of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) took place in Copenhagen, Denmark. Bringing together over 7,000 experts and industry practitioners from more than 90 countries worldwide, the congress featured eight thematic sessions covering cutting edge research releases, multidisciplinary symposiums, discussions on emerging AI enabled technologies, and extensive hands on clinical training sessions.
At this year’s congress, Kossel made a significant appearance, showcasing its peripheral interventional product portfolio CE certified, including Falspeed® PTA Balloon Dilatation Catheter, Falexpand® HP PTA Balloon Dilatation Catheter, Tanghulu® PTA Balloon Dilatation Catheter and Giranel® Guiding Sheath Set. The display demonstrated the technological achievements and strengths of a Chinese enterprise in the field of peripheral intervention to global peers.
Multiple lectures and case discussion sessions were organized focusing on complex lower extremity lesions, endovascular therapy, and clinical translation of innovative medical devices, where numerous European clinicians shared state of the art diagnosis and treatment experiences. Leveraging this academic exchange platform, Kossel gathered extensive on site clinical feedback to inform ongoing product development, and is committed to delivering one stop vascular interventional solutions for diverse clinical scenarios and lesion types.
During the congress, Kossel received visits from distributors, clinicians and industry representatives across Europe and the Middle East, including representatives from Denmark, Germany, Sweden, Italy, Turkey and Saudi Arabia. In depth discussions were held with guests covering Kossel’s full portfolio of electrophysiology, coronary and peripheral interventional products, with detailed exchanges around clinical value, technical advantages and regional cooperation models.
Building on insights and connections gained at this premier industry congress, Kossel will continue executing its “Local Base, Global Reach” international strategy. The company will consolidate its existing partner network, steadily expand into uncovered regional markets across Europe, support long term business growth in Europe and surrounding regions, and bring high quality vascular interventional solutions to more patients and healthcare providers overseas.